{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:36:24Z","timestamp":1774118184794,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.pupt.2011.10.004","type":"journal-article","created":{"date-parts":[[2011,10,27]],"date-time":"2011-10-27T05:07:57Z","timestamp":1319692077000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD"],"prefix":"10.1016","volume":"25","author":[{"given":"K.M.C.","family":"Verhamme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.M.","family":"Afonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"van Noord","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Haag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Koudstaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.G.O.","family":"Brusselle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.C.J.M.","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.pupt.2011.10.004_bib1","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1164\/ajrccm.163.5.2101039","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI\/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary","volume":"163","author":"Pauwels","year":"2001","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"10","key":"10.1016\/j.pupt.2011.10.004_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/thx.2006.063271","article-title":"Tiotropium for stable chronic obstructive pulmonary disease: a meta-analysis","volume":"61","author":"Barr","year":"2006","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.pupt.2011.10.004_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-149-6-200809160-00004","article-title":"Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease","volume":"149","author":"Lee","year":"2008","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1016\/j.pupt.2011.10.004_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.300.12.1439","article-title":"Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"300","author":"Singh","year":"2008","journal-title":"JAMA"},{"issue":"15","key":"10.1016\/j.pupt.2011.10.004_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","article-title":"A\u00a04-year trial of tiotropium in chronic obstructive pulmonary disease","volume":"359","author":"Tashkin","year":"2008","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pupt.2011.10.004_bib6","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1164\/rccm.200906-0876OC","article-title":"Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease","volume":"180","author":"Celli","year":"2009","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"12","key":"10.1016\/j.pupt.2011.10.004_bib7","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJMp1008502","article-title":"The safety of tiotropium \u2013 the FDA\u2019s conclusions","volume":"363","author":"Michele","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.pupt.2011.10.004_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.7326\/0003-4819-119-10-199311150-00011","article-title":"The introduction of computer-based patient records in The Netherlands","volume":"119","author":"van der Lei","year":"1993","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.pupt.2011.10.004_bib9","series-title":"International classification of primary care","author":"Lamberts","year":"1987"},{"key":"10.1016\/j.pupt.2011.10.004_bib10","first-page":"49","article-title":"The Dutch approach to computerized drug information: conceptual basis and realization","volume":"5","author":"DeSmet","year":"1988","journal-title":"Journal of Social and Administrative Pharmacy"},{"issue":"4\u20135","key":"10.1016\/j.pupt.2011.10.004_bib11","first-page":"339","article-title":"Postmarketing surveillance based on electronic patient records: the IPCI project","volume":"38","author":"Vlug","year":"1999","journal-title":"Methods of Information in Medicine"},{"issue":"8","key":"10.1016\/j.pupt.2011.10.004_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/pds.1082","article-title":"Guidelines for good pharmacoepidemiology practices (GPP)","volume":"14","author":"Epstein","year":"2005","journal-title":"Pharmacoepidemiology and Drug Safety"},{"issue":"11","key":"10.1016\/j.pupt.2011.10.004_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s10654-006-9066-1","article-title":"Chronic obstructive pulmonary disease severity and cardiovascular outcomes","volume":"21","author":"Curkendall","year":"2006","journal-title":"European Journal of Epidemiology"},{"issue":"6","key":"10.1016\/j.pupt.2011.10.004_bib14","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1378\/chest.127.6.1890","article-title":"Development and validation of a survey-based COPD severity score","volume":"127","author":"Eisner","year":"2005","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.pupt.2011.10.004_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1023\/A:1021235123382","article-title":"Validation of general practitioner-diagnosed COPD in the UK general practice research database","volume":"17","author":"Soriano","year":"2001","journal-title":"European Journal of Epidemiology"},{"issue":"3","key":"10.1016\/j.pupt.2011.10.004_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1164\/rccm.2110093","article-title":"Hospitalizations and mortality in the Lung Health Study","volume":"166","author":"Anthonisen","year":"2002","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"5","key":"10.1016\/j.pupt.2011.10.004_bib17","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1164\/ajrccm.167.5.955","article-title":"Ipratropium and lung health study","volume":"167","author":"Lanes","year":"2003","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.pupt.2011.10.004_bib18","author":"FDA hwfgddpduh"},{"key":"10.1016\/j.pupt.2011.10.004_bib19","article-title":"Cardiovascular safety of tiotropium in patients with COPD","author":"Celli","year":"2009","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.pupt.2011.10.004_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2147\/COPD.S3530","article-title":"Safety, tolerability and risk benefit analysis of tiotropium in COPD","volume":"3","author":"Oba","year":"2008","journal-title":"International Journal of Chronic Obstructive Pulmonary Disease"},{"issue":"10","key":"10.1016\/j.pupt.2011.10.004_bib21","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.rmed.2009.05.020","article-title":"Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: systematic review with meta-analysis","volume":"103","author":"Rodrigo","year":"2009","journal-title":"Respiratory Medicine"},{"issue":"4","key":"10.1016\/j.pupt.2011.10.004_bib22","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s10654-007-9106-5","article-title":"Cardiovascular and respiratory hospitalizations and mortality among users of tiotropium in Denmark","volume":"22","author":"de Luise","year":"2007","journal-title":"European Journal of Epidemiology"},{"issue":"12","key":"10.1016\/j.pupt.2011.10.004_bib23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2165\/00002018-200730120-00007","article-title":"Comparative safety of long-acting inhaled bronchodilators: a cohort study using the UK THIN primary care database","volume":"30","author":"Jara","year":"2007","journal-title":"Drug Safety"},{"issue":"9","key":"10.1016\/j.pupt.2011.10.004_bib24","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7326\/0003-4819-154-9-201105030-00003","article-title":"Comparison of inhaled long-acting {beta}-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study","volume":"154","author":"Gershon","year":"2011","journal-title":"Annals of Internal Medicine"},{"issue":"12","key":"10.1016\/j.pupt.2011.10.004_bib25","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa1008378","article-title":"Tiotropium versus salmeterol for the prevention of exacerbations of COPD","volume":"364","author":"Vogelmeier","year":"2011","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pupt.2011.10.004_bib26","doi-asserted-by":"crossref","first-page":"d3215","DOI":"10.1136\/bmj.d3215","article-title":"Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials","volume":"342","author":"Singh","year":"2011","journal-title":"British Medical Journal"}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553911001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553911001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:27:31Z","timestamp":1761082051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553911001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1094553911001507"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2011.10.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2011.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}